Brandon McNally, MD
Dermatopathology · Grandville, MINPI 1073740833
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 433 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations.
Across 433 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Johnson & Johnson$1K
- AbbVie$1K
- Sanofi$663
- Dermavant Sciences, Inc.$442
- Regeneron Healthcare Solutions, Inc.$399
- plus $3K from 27 others
What the payments were for
- Food & beverage$7,52494%
- Education$4596%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 66 | $1,424 |
| Johnson & Johnson(2 entities) | 45 | $1,081 |
| AbbVie | 60 | $1,030 |
| Sanofi | 33 | $663 |
| Dermavant Sciences, Inc. | 54 | $442 |
| Regeneron Healthcare Solutions, Inc. | 19 | $399 |
| Pfizer | 21 | $337 |
| Incyte Corporation | 14 | $322 |
| Amgen | 15 | $281 |
| Boehringer Ingelheim | 13 | $278 |
| Sun Pharmaceutical Industries Inc. | 9 | $217 |
| E.r. Squibb & Sons, L.L.C. | 11 | $213 |
| Arcutis Biotherapeutics, Inc. | 10 | $203 |
| Organon | 15 | $192 |
| UCB, Inc. | 8 | $173 |
| Lilly USA, LLC | 9 | $151 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $72 |
| Fresenius Kabi USA, LLC | 3 | $65 |
| Biofrontera Inc. | 3 | $59 |
| Galderma Laboratories, L.p. | 3 | $57 |
| Almirall LLC | 3 | $53 |
| Kyowa Kirin, Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $34 |
| LNHC, Inc | 2 | $29 |
| Blueprint Medicines Corporation | 1 | $28 |
| VYNE Pharmaceuticals Inc. | 1 | $25 |
| Krystal Biotech Inc | 1 | $21 |
| Mylan Institutional Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Biocon Biologics Inc | 1 | $17 |
| Organogenesis Inc. | 1 | $17 |
| LEO Pharma Inc. | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $8 |
How this compares
$7,983 in reported general payments places this provider in the 85th percentile of 28 dermatopathology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 161 | $9,097 |
| Clobetasol Propionate | 69 | $1,888 |
| Triamcinolone Acetonide | 78 | $983 |
| Ketoconazole | 48 | $746 |
| Metronidazole | 11 | $429 |
| Doxycycline Hyclate | 26 | $275 |
| ValacyclovirValacyclovir Hcl | 13 | $238 |
| Mupirocin | 38 | $221 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $80 |
| Hydrocortisone | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Grandville
- Juan VasquezGrandville$13K
- David StockmanSaginaw$24K
- Marek StawiskiGrand Rapids$23K
- Nicole BossenbroekNorton Shores$6K
- Darius MehreganMonroe$4K
- John PelachykColumbus$3K
- Fred NoviceBloomfield Hills$2K
- Neldagae ChisaBloomfield Hills$2K
- Leah HooeyGrand Rapids$1K
- Daniel DapprichGrand Rapids$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.